AstraZeneca and CSPC Pharmaceuticals have announced a new collaboration agreement for the development of therapies for obesity and type 2 diabetes.

Grounded in data-driven human insights and representing the perspectives of both patients and HCPs, medical affairs can ...

AstraZeneca has announced a $15bn investment in China by 2030 to expand manufacturing and R&D.

GC Therapeutics has appointed Kate Haviland as Board Chair.

Genentech has doubled its initial investment in a new manufacturing facility located in Holly Springs, North Carolina, bringing investment in the project to around $2bn.

Genentech has announced positive topline results from a phase 2 trial of CT-388, its investigational therapy to treat obesity ...

Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.

GlaxoSmithKline (GSK) has announced that Arexvy, its respiratory syncytial virus (RSV) vaccine, has received expanded ...

Sanofi has announced that its amlitelimab has shown positive results in the treatment of patients 12 years and older with ...

Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.

Sanofi and Regeneron’s Dupixent (dupilumab) has received positive final draft guidance from the National Institute for Health ...

Tamer Mohamed, founder and CEO at Aspect Biosystems added: “Our partnership with Novo Nordisk combines more than a century of their global leadership in the fight against diabetes with Aspect’s ...